A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT06108492 · RECRUITING
Trial details
- NCT number
- NCT06108492
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2026-12-31
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.